In this thesis we aim to optimize existing immunotherapy for hepatocellular carcinoma (HCC) with a strong emphasis on checkpoint inhibition. We aim to detect tumor-associated mutations in paired circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in a western cohort of HCC patients.
|Award date||1 Jun 2021|
|Place of Publication||Rotterdam|
|Publication status||Published - 1 Jun 2021|
Bibliographical noteThe research was funded by:
- China Scholarship Council
- Nederlandse Vereniging Voor Gastro-enterologie